Skip to main content

Table 1 Demographics and clinicopathological parameters in patients with PDAC

From: Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma

Variables

PDAC (N = 85)

Age: Mean ± SD (years)

65 ± 10

Gender

 Male

55 (65%)

 Female

30 (35%)

Tumor size

  ≤ 2 cm

18 (21%)

  > 2 cm

67 (79%)

Tumor location

 Head

63 (74%)

 Tail

22 (26%)

LN metastasis

54 (64%)

LVI

40 (48%)

PNI

61 (72%)

No neoadjuvant

75 (88%)

Stage

 Stage I, II

24 (28%)

 Stage III, IV

61 (72%)

Tumor grade

 Low grade (1/2)

56 (66%)

 High grade (3)

29 (34%)

  1. Abbreviations: PDAC pancreatic ductal adenocarcinoma;
  2. SD standard deviation, LVI lymphovascular invasion;
  3. LN lymph node, PNI perineural invasion